Compare STMicroelectronics NV (STM) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
STMicroelectronics NV vs State Street SPDR S&P Biotech ETF — how do they compare? STMicroelectronics NV trades at $65.4 (market cap $55.80B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: STMicroelectronics NV pays a 0.58% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, STMicroelectronics NV nearer its low. Which is the better fit depends on your goals.
| STM | XBI | |
|---|---|---|
Market Cap | $55.80B | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $79.91 | $164.28 |
52-Week Low | $21.20 | $85.16 |
Enterprise Value | $54.01B | — |
Dividend Yield | 0.58% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
